Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

NCT04509635 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Liver Metastases
Cetuximab

Interventions

DRUG: Cetuximab
DRUG: Chemotherapy

Sponsor

Fudan University